While top executives did not earn any annual bonus, Medtronic's board compensation committee did make changes, allowing the top leaders more long-term equity awards as an incentive to lead through the pandemic.
The board committee made other adjustments so more than 63,000 employees who are eligible for the annual awards would receive something. The compensation committee instead made annual awards based on performance in the first three quarters of the year resulting in a payment at 82.8% of the target for the year.
The most senior leaders didn't get that adjustment and instead received a "special, one-time grant of unvested stock options in August 2020 to align pay with the performance delivered to our stockholders as our business recovers from the pandemic."
Ishrak's options awarded under that plan had a grant date value of $2,530,000 and a 10-year term. That amount and those of the other senior leaders will be reflected in next year's summary compensation table of the proxy.
In January, Ishrak was also named chairman of California-based Intel Corp. after joining that company's board in 2017.